Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer’s disease: A systematic review

Selia Chowdhury, Nurjahan Shipa Chowdhury

View at source ↗Review76 citations
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.

Record

Archive ID
doi:10.1177/03946320231209839
Published
Jan 1, 2023
Venue
International Journal of Immunopathology and Pharmacology
DOI
10.1177/03946320231209839
PubMed
37902139
Categories
Alzheimer's disease research and treatments
License
cc-by-nc
Provenance
openalex

Topics